Diabetes Care
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Diabetes Care 25:1755-1760, 2002
© 2002 by the American Diabetes Association, Inc.


Epidemiology/Health Services/Psychosocial Research
Original Article

Rapid Early Growth Is Associated With Increased Risk of Childhood Type 1 Diabetes in Various European Populations

the EURODIAB Substudy 2 Study Group


    ABSTRACT
 TOP
 ABSTRACT
 INTRODUCTION
 RESEARCH DESIGN AND METHODS
 RESULTS
 CONCLUSIONS
 APPENDIX
 References
 
OBJECTIVE—To confirm that early growth is associated with type 1 diabetes risk in European children and elucidate any role of infant feeding.

RESEARCH DESIGN AND METHODS—Five centers participated, each with a population-based register of type 1 diabetes diagnosed at <15 years of age. Control subjects were randomly chosen from population registers, schools, or polyclinics. Growth data were obtained from routine records and infant feeding information from parental questionnaire or interview. Patient/control subject differences in mean standard deviation score (SDS) were obtained for each center and pooled. Odds ratios (ORs) were pooled by the Mantel-Haenszel method, and logistic regression was used to adjust for confounders.

RESULTS—Growth data were available for 499 patients and 1,337 control subjects. Height and weight SDS were significantly increased among patients from 1 month after birth, the maximum differences of 0.32 (95% CI 0.14–0.50) and 0.41 (0.26–0.55), respectively, occurring between 1 and 2 years of age. Significant excesses in BMI SDS were observed from 6 months of age, with the largest difference of 0.27 (0.10, 0.44) evident between 1 and 2 years. Breast-feeding was associated with reduced disease risk, OR 0.75 (0.58–0.96). Introduction of cow’s milk, formula, or solid foods before 3 months was not associated with significant risk elevation.

CONCLUSION—Increased early growth is associated with disease risk in various European populations. Any role of infant feeding in this association remains unclear.

Abbreviations: OR, odds ratio • SDS, standard deviation score


    INTRODUCTION
 TOP
 ABSTRACT
 INTRODUCTION
 RESEARCH DESIGN AND METHODS
 RESULTS
 CONCLUSIONS
 APPENDIX
 References
 
In 1975, it was reported that the incidence of childhood type 1 diabetes peaks at about 11 years for both boys and girls (1), and it has subsequently been suggested that this is due to the high growth rate during puberty causing an increased demand on the insulin-producing ß-cells, thus precipitating disease occurrence (2,3). Two decades later, a large population-based study using routinely recorded data showed that a high growth rate many years before disease onset was also a risk factor (4). No clear association with weight for height was shown, but later studies reported greater weight gains during the first year of life in children who later developed diabetes compared with control subjects (5,6), as well as increased BMI in the first year of life and an increased height in the next 2 years (7). Recently an increased relative weight has been reported in such children throughout childhood (8). It has been speculated that the key factor behind these observations is the overfeeding of children, which will accelerate growth as measured by both increased weight and height (9).

It has also been suggested that the greater weight gain in childhood observed in diabetic children before the onset of disease may be linked with higher rates of bottle-feeding in these children, explaining the frequently observed association between diabetes and a short duration of breast-feeding (and the consequent early introduction of cow’s milk) (10). However, one study has concluded, to the contrary, that the introduction of formula feeding before 3 months of age and rapid growth in infancy are independent risk factors for childhood type 1 diabetes (6).

We have collected data on infant feeding practices and routine growth measurements for children before being diagnosed with childhood type 1 diabetes and for age-matched control children in a large, population-based, case-control study of environmental risk factors for this disease in different European populations with a wide range of incidence rates. In this report, we wanted to confirm in different European settings the association between various measures of growth in early childhood and subsequent risk of type 1 diabetes and to explore any role of infant feeding.


    RESEARCH DESIGN AND METHODS
 TOP
 ABSTRACT
 INTRODUCTION
 RESEARCH DESIGN AND METHODS
 RESULTS
 CONCLUSIONS
 APPENDIX
 References
 
Each of the eight centers that participated in EURODIAB Substudy 2 had a population-based register of childhood-onset diabetes operating in accordance with the methodology used by the EURODIAB ACE (Aetiology of Childhood Diabetes on an Epidemiological Basis) Group (11), ensuring that patients were obtained from a temporally and geographically defined study base in each center. After consultation with the study coordinators, a population-based sample of control children, matched to the patients in age distribution, was obtained in each center using sources that depended on local circumstances as previously described (12). An agreed-on set of core variables, including information about infant feeding (duration of breast-feeding, age at introduction of formula feeding, dairy milk, foods containing fruit, vegetable, fish, meat, and egg), was then collected from parents by interview or questionnaire. Growth data were obtained from routine assessments recorded in the child’s health care booklet or clinic record; however, three of the eight centers (Bulgaria, Romania, and Leeds) had difficulty in complying with this element of the study and are not included in this report. All information was transferred to a standardized coding sheet and records (stripped of identifying features) were dispatched to a single center for data entry and analysis.

Height and weight measurements were used in the analysis only if the measurements were taken before the date of diagnosis for the patients or a corresponding qualifying date for control subjects, the midpoint of the center’s period of patient recruitment. Because separate growth standards were not available for all the participating centers, the height, weight, and BMI (weight divided by height squared) values were adjusted for age and sex by converting to standard deviation score (SDS) using the computerized 1990 British standard (13). The score represents the number of standard deviations that a child’s growth measurement differs from the mean of the distribution in British children of the same age and sex. Birth scores were adjusted for gestational age. To ensure that a child with multiple measurements available in a period contributed only once to the analysis for the period, scores for the child were averaged before analysis to give a result that was representative of the child’s growth status in the period. The statistical efficiency of this simple approach was subsequently investigated using an alternative, more complex approach based on general estimating equations. Patient/control subject differences in mean SDS were calculated within each center, and these differences were then weighted and pooled. A test of the pooled difference was obtained by multiple regression analysis, and a test of heterogeneity in these differences between centers was obtained by adding an interaction term between center and patient/control status to the multiple regression (14). Children were designated as being overweight between the ages of 2 and 6 years if BMI exceeded an age- and sex-specific cutoff defined according to a recently proposed international standard (15). These cutoff values range from 18.41 and 18.02 kg/m2 for boys and girls aged 2 years to 17.55 and 17.34 kg/m2 for boys and girls aged 6 years. The Mantel-Haenszel approach was used to pool odds ratios (ORs) for exposures (e.g., breast-feeding, early introduction of solid foods, overweight) obtained from each center, to test the significance of the combined OR, and to test for heterogeneity in the ORs between centers (16). To adjust for potential confounders, logistic regression analysis was used with terms included in the model to represent centers. Statistical analyses were performed using the SPSS (SPSS, Chicago, IL) and Stata (Stata, College Station, TX) packages.


    RESULTS
 TOP
 ABSTRACT
 INTRODUCTION
 RESEARCH DESIGN AND METHODS
 RESULTS
 CONCLUSIONS
 APPENDIX
 References
 
In the five participating centers, 683 children with diabetes onset before the age of 15 years and 2,167 age-matched control subjects were selected to take part in the study. The parents of 610 (89.3%) of the patients and 1,616 (74.6%) of the control subjects responded to a questionnaire or invitation to interview; growth data were available for 499 (81.8%) of the responding patients and 1,337 (82.7%) of responding control subjects (Table 1).


View this table:
[in this window]
[in a new window]
 
Table 1— Summary of participants in the five study centers

 
The differences in mean height, weight, and BMI SDS between patients and control subjects are shown in Table 2 for various periods after birth. Significant differences in height and weight SDS were evident even at birth, and these differences increased in magnitude to a maximum between ages 1 and 2 years. There were only slight differences in BMI at birth, but these differences also increased in magnitude with increasing age and were significant after 6 months. Differences showed a similar pattern for boys and girls, although they tended to be larger for boys at most ages. Figure 1 presents the results between the ages of 1 and 2 years by study center. Tests for heterogeneity showed that differences between centers were not significant. In terms of the original variables, these differences in SDS between 1 and 2 years of age correspond roughly to differences of 1 cm, 0.5 kg, and 0.4 kg/m2 for height, weight, and BMI, respectively. To demonstrate that such apparently small differences may nevertheless translate to meaningful increases in disease risk, childhood obesity (as defined by a recently proposed international standard), based on the first available BMI measurement after the age of 2 years, was associated with an increased disease risk: OR 1.73 (95% CI 1.19–2.52), with no evidence of heterogeneity between centers.


View this table:
[in this window]
[in a new window]
 
Table 2— Patient/control subject differences in SDS for growth measurements taken at different ages pooled over five centers

 


View larger version (14K):
[in this window]
[in a new window]
 
Figure 1— Differences in means (95% CI) between patients and control subjects in height, weight, and BMI SDS at age 1–2 years, pooled over centers. The box size indicates the weight contributed by each center to the pooling.

 
When growth data were examined in relation to the number of years before diagnosis (or the corresponding qualifying date for control subjects), weight and height scores were significantly larger in patients than in control subjects for up to 6 years before diagnosis and BMI scores for up to 4 years before diagnosis (Table 3). In the year directly preceding diagnosis, all three scores were still larger in patients, but only the comparison of weight scores attained significance.


View this table:
[in this window]
[in a new window]
 
Table 3— Patient/control subject differences in SDS for growth measures taken in periods before diagnosis (patients) or qualifying date (control subjects) pooled over five centers

 
Breast-feeding of any duration was associated with a reduction in risk, with a pooled OR of 0.75 (95% CI 0.58–0.96) and no evidence of heterogeneity between centers. The age at which various foods were introduced to the diet was also examined; the introduction before 3 months of age of cow’s milk (OR 1.15, 95% CI 0.74–1.81), cow’s milk or formula (OR 1.01, 95% CI 0.81–1.25), or solid foods (OR 0.74, 95% CI 0.57–0.95) was not associated with any significant elevation in risk. Indeed the finding for solid foods suggested a reduced risk, although there was significant heterogeneity between centers (P < 0.001), with the Lithuanian center showing a significantly increased risk and the Latvian and Luxembourg centers significantly reduced risks. None of these results were altered by adjustment for several potential confounding variables (maternal age at delivery, neonatal jaundice, neonatal respiratory infection, vitamin D supplementation, and asthma).

When these infant feeding indicators were examined in relation to growth data, the early introduction of solids was associated only with significantly higher height SDS at the age of 6–12 months. The early introduction of cow’s milk or formula was associated with lower weight and BMI SDS between 1 and 6 months, but there was evidence of heterogeneity, indicating that this finding was not consistent across centers.

Both height SDS and BMI SDS between 1 and 2 years were independently predictive of diabetes when simultaneously included in a logistic regression analysis: OR 1.36 (95% CI 1.17–1.58) and 1.35 (95% CI 1.15–1.57), respectively. These results were little altered by adjustment for a range of possible confounders (maternal age at delivery, neonatal jaundice, neonatal respiratory infection, vitamin D supplementation, and asthma). Furthermore when the various indicators of infant feeding were included in the model, similar results were obtained, thus providing no evidence to support the hypothesis that the infant feeding factors played a role in explaining the excess risk associated with increased growth. The OR associated with breast-feeding, in particular, in this analysis remained significant, OR 0.59 (95% CI 0.35–0.97), indicating that a high early growth rate and failure to breast-feed are independent predictors of disease risk.


    CONCLUSIONS
 TOP
 ABSTRACT
 INTRODUCTION
 RESEARCH DESIGN AND METHODS
 RESULTS
 CONCLUSIONS
 APPENDIX
 References
 
As standards for growth were not available for each of the centers participating in our study, we chose to use the British growth standard to perform our analyses. The appropriateness of this standard could be questioned, and we therefore repeated our analyses using a standard derived from the U.S. Health Examination Survey (17,18). Although individuals’ scores differed between the two standards in their absolute values, we found that the differences in mean scores (Tables 2 and 3) were robust to the choice of standard.

In contrast to some recent studies (7,8), growth measurements for many of the children in our study were too sparse to permit more sophisticated longitudinal analysis methods to be employed. However, we did investigate if there was much loss of statistical efficiency through the simple averaging of scores within each time period for each subject. When we repeated the analyses in Table 2 using a general estimating equation approach to analyze all growth measurements in each time period, we obtained similar estimates, with no obvious gain in efficiency as judged by the width of the 95% CIs. The high levels of statistical significance attained in many of our cross-sectional comparisons mean that, even if a correction were employed to allow for analyses of multiple time periods, the interpretation of our findings would remain clear. We confirm that, as early as the first few years of life, height, weight, and BMI SDS are risk determinants for childhood-onset type 1 diabetes in different areas of Europe. Also, by looking at periods before diagnosis, an increased weight, height, and BMI can be seen from 1 year and up to 5–6 years before the onset of clinical disease.

Because adequate insulin supply is a fundamental prerequisite for normal growth in children, measurements taken around the time of disease onset may be blurred by the duration and magnitude of insulin deficiency. This may explain why the patient/control subject differences were reduced in the year before diagnosis (Table 3) even though we omitted measurements taken within a month of diagnosis. Although this could also explain why a review of early studies on children’s height at the time of diagnosis of type 1 diabetes noted conflicting results (19), more recent studies that have incorporated appropriate control groups have more consistently reported that diabetic children are taller at diagnosis (4,2022), although often the results were not consistent in all age-groups. Interestingly, when we examined our results by age- group, a significant excess in height SDS in the year before diagnosis was observed only for those with onset in the 5- to 9-year-age-group, a finding that supports two of these studies (20,21).

Birth weight has also been studied as a possible indicator of subsequent type 1 diabetes risk. In many of the smaller studies, no consistent association has been found (5,2327). However, two large register-based studies have reported a weak but uniformly increasing risk with increasing birth weight (28,29), and a previous analysis of our own data suggested a reduced risk associated with having a birth weight under 2,500 g (30). We were not able to confirm reports that onset before 5 years of age was associated with low birth weight (5,31).

Growth depends on genetic, nutritional, and hormonal factors, and we cannot exclude the possibility that the association between a high growth rate and childhood diabetes is due to a common genetic trait. However, the slightly stronger association between diabetes and the gain in weight as opposed to height found in our study and others (5,8) might suggest that nutritional factors are responsible. As in another recent study (6), we could not confirm a previous suggestion that an early introduction of solid foods, defined by the authors as occurring before 3 months of age (32), was associated with an increased risk. Indeed, pooled over all centers, our results suggested a reduction in risk, but there was evidence of heterogeneity in the findings between centers, possibly suggesting that early exposure to solid foods may not be a primary risk factor. Limitations and biases in parental recall of infant feeding practices may also explain these contradictory results, and ideally, overfeeding would be measured by a prospective evaluation of energy intake during childhood.

A relationship between growth and childhood diabetes risk is central to the accelerator hypothesis (33), which argues that the distinction between type 1 and type 2 diabetes is becoming increasingly blurred and that physical inactivity and weight gain lead to insulin resistance, which is responsible for the rising incidence of both type 1 and type 2 diabetes in industrially developed societies. The association between growth and childhood diabetes risk described in this study is also consistent with the ecological association between gross national product and diabetes incidence in different countries (34), since childhood growth is known to reflect population wealth (35). Some part of the association between growth and childhood diabetes risk could be attributable to socioeconomic circumstances, but these are difficult to measure, especially in a multicenter study such as ours.

In conclusion, our population-based patient/control subject study confirms previous reports showing that rapid growth in early childhood measured by height, weight, or BMI is a risk factor for childhood-onset diabetes in various European populations.


    APPENDIX
 TOP
 ABSTRACT
 INTRODUCTION
 RESEARCH DESIGN AND METHODS
 RESULTS
 CONCLUSIONS
 APPENDIX
 References
 
Study coordinators
Gisela Dahlquist, Department of Pediatrics, Umeå University, Sweden; Chris Patterson, Department of Epidemiology and Public Health, Queen’s University Belfast, U.K.; Gyula Soltész, Department of Pediatrics, University of Pécs, Hungary

Study center leaders
Austria: Edith Schober and Ursula Schneider, Department of Pediatrics, University of Vienna, Austria Bulgaria: Svetla Goranova, Denka Stovanova, and Mirela Ivanova, Children’s Diabetic Center, Sofia, Bulgaria Lithuania: Brone Urbonaite and Auste Pundziute-Lycka, Institute of Endocrinology, Kaunas Medical University, Lithuania Latvia: Girts Brigis and Ilona Rubietza, Department of Public Health and Epidemiology, Medical Academy of Latvia, Riga, Latvia Luxembourg: Carine de Beaufort, Clinique Pédiatrique, Luxembourg Romania: Anne-Marie Konnerth and Constantin Ionescu-Tirgoviste, Department of Diabetes, Nutrition and Metabolic Disease, University of Bucharest, Romania U.K. (Leeds): Patricia McKinney, Institute of Epidemiology and Health Services Research, University of Leeds, U.K. U.K. (Northern Ireland): Chris Patterson, Ruth Greenlees, and David Hadden, Department of Epidemiology and Public Health, Queen’s University Belfast, U.K.


    Acknowledgments
 
This was part of the EURODIAB ACE study supported in part by the European Community Concerted Action Program (grants BMH1-CT92-0043 and BMH4-CT96-0577). Local grants were supplied from the Swedish Medical Research Council (no. 07531), the British Diabetic Association, the Hungarian National Research Fund (no. 019192), and CRP-Sauté, Luxembourg.


    Footnotes
 
Address correspondence to Dr. Chris Patterson, Department of Epidemiology and Public Health, Queen’s University Belfast, Grosvenor Rd., Belfast, BT12 6BJ U.K. E-mail: c.patterson{at}qub.ac.uk.

Received for publication 13 December 2001 and accepted in revised form 3 July 2002.

A table elsewhere in this issue shows conventional and Système International (SI) units and conversion factors for many substances.


    References
 TOP
 ABSTRACT
 INTRODUCTION
 RESEARCH DESIGN AND METHODS
 RESULTS
 CONCLUSIONS
 APPENDIX
 References
 

  1. Bloom A, Hayes TM, Gamble DR: Register of newly diagnosed diabetic children. BMJ 3: 580–583, 1975
  2. La Porte RE, Fishbein HA, Drash AL, Kuller LH, Schneider BB, Orchard TJ, Wagener DK, the Pittsburgh Insulin-Dependent Diabetes Mellitus Registry: The incidence of insulin-dependent diabetes mellitus (IDDM) in Allegheny County, Pennsylvania (1965–1976). Diabetes 30: 279–284, 1981[Abstract]
  3. Dahlquist G, Gustavsson KH, Holmgren G, Hägglöf B, Larsson G, Nilsson KO, Samuelsson G, Sterky G, Thalme B, Wall S: The incidence of diabetes mellitus in Swedish children 0–14 years of age. Acta Paediatr Scand 71: 7–14, 1982[Medline]
  4. Blom L, Persson LÅ, Dahlquist G: A high linear growth is associated with an increased risk of childhood diabetes mellitus. Diabetologia 35: 528–533, 1992[Medline]
  5. Johansson C, Samuelsson U, Ludvigsson J: A high weight gain early in life is associated with an increased risk of type I (insulin-dependent) diabetes mellitus. Diabetologia 37: 91–94, 1994[Medline]
  6. Hypponen E, Kenward MG, Virtanen SM, Piitulainen A, Virta-Autio P, Tuomilehto J, Knip M, Åkerblom HK: Infant feeding, early weight gain, and risk of type I diabetes. Childhood Diabetes in Finland (DiMe) Study Group. Diabetes Care 22: 1961–1965, 1999[Abstract/Free Full Text]
  7. Bruining GJ: Association between infant growth before onset of juvenile type-1 diabetes and autoantibodies to IA-2. Lancet 356: 655–656, 2000[Medline]
  8. Hypponen E, Virtanen SM, Kenward MG, Knip M, Åkerblom H: Obesity, increased linear growth, and risk of type I diabetes in children. Diabetes Care 23: 1755–1760, 2000[Abstract/Free Full Text]
  9. Dahlquist G: Diabetes in children: the etiology in an epidemiological perspective. In The Diabetes Annual 8. Marshall SM, Home PD, Eds. Amsterdam, Elsevier Science B.V., 1994
  10. Gerstein HC: Cow’s milk exposure and type I diabetes mellitus: a critical review of the literature. Diabetes Care 17: 13–19, 1994[Abstract]
  11. EURODIAB ACE Study Group: Variation and trends in the incidence of childhood diabetes in Europe. Lancet 355: 873–876, 2000[Medline]
  12. The EURODIAB Substudy 2 Study Group: Vitamin D supplement in early childhood and risk for type I (insulin-dependent) diabetes mellitus. Diabetologia 42: 51–54, 1999[Medline]
  13. Cole TJ, Freeman JV, Preece MA: British 1990 growth reference centiles for weight, height, body mass index and head circumference fitted by maximum penalised likelihood. Stat Med 17: 404–429, 1998
  14. Fleiss JL: The Design and Analysis of Clinical Experiments. New York, NY, Wiley, 1986, p. 150–154
  15. Cole TJ, Bellizzi MC, Flegal KM, Dietz WH: Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ 320: 1–6, 2000[Abstract/Free Full Text]
  16. Breslow NE, Day NE: Statistical Methods in Cancer Research. Volume 1: The Analysis of Case-Control Studies. Oxford, U.K., Oxford University Press, 1993
  17. Dibley MJ, Goldsby JB, Staehling NW, Trowbridge FL: Development of normalized curves for the international growth reference: historical and technical considerations. Am J Clin Nutr 46: 736–748, 1987[Abstract/Free Full Text]
  18. Dean AG, Dean JA, Coulombier D, Brendel KA, Smith DC, Burton AH, Dicker RC, Sullivan K, Fagan RF, Arner TG: Epi Info, Version 6: A Word-Processing, Database, and Statistics Program for Public Health on IBM-compatible Microcomputers. Atlanta, GA, Centers for Disease Control and Prevention, 1995
  19. Drayer NM: Height of diabetic children at onset of symptoms. Arch Dis Child 49: 616–620, 1974[Medline]
  20. Songer TJ, LaPorte RE, Tajima N, Orchard TJ, Rabin BS, Eberhardt MS, Dorman JS, Cruickshanks KJ, Cavender DE, Becker DJ: Height at diagnosis of insulin dependent diabetes in patients and their non-diabetic family members. BMJ 292: 1419–1422, 1986
  21. Brown M, Ahmed ML, Clayton KL, Dunger DB: Growth during childhood and final height in type I diabetes. Diabet Med 11: 182–187, 1994[Medline]
  22. Price DE, Burden AC: Growth of children before onset of diabetes. Diabetes Care 15: 1393–1395, 1992[Abstract]
  23. Baum JD, Ounsted M, Smith MA: Weight gain in infancy and subsequent development of diabetes mellitus in childhood (Letter). Lancet 2: 866, 1975
  24. Dahlquist G, Källén B: Maternal-child blood group incompatibility and other perinatal events increase the risk for early-onset type I (insulin-dependent) diabetes mellitus. Diabetologia 35: 671–675, 1992[Medline]
  25. Patterson CC, Carson DJ, Hadden DR, Waugh NR, Cole SK: A case-control investigation of perinatal risk factors for childhood IDDM in Northern Ireland and Scotland. Diabetes Care 17: 376–381, 1994[Abstract]
  26. Jones ME, Swerdlow AJ, Gill LE, Goldacre MJ: Pre-natal and early life risk factors for childhood diabetes mellitus: a record linkage study. Int J Epidemiol 27: 444–449, 1998[Abstract/Free Full Text]
  27. Podar T, Onkamo P, Forsen T, Karvonen M, Tuomilehto-Wolf E, Tuomilehto J: Neonatal anthropometric measurements and risk of childhood-onset type I diabetes. Diabetes Care 22: 2092–2094, 1999
  28. Dahlquist G, Bennich SS, Kallen B: Intrauterine growth pattern and risk of childhood onset insulin dependent (type I) diabetes: population based case-control study. BMJ 313: 1174–1177, 1996[Abstract/Free Full Text]
  29. Stene LC, Magnus P, Lie RT, Sovik O, Joner G, and the Norwegian Childhood Diabetes Study Group: Birth weight and childhood onset type I diabetes: population based cohort study. BMJ 322: 889–892, 2001[Abstract/Free Full Text]
  30. Dahlquist G, Patterson CC, Soltész G: Perinatal risk factors for childhood type I diabetes in Europe. The EURODIAB Substudy 2 Study Group. Diabetes Care 22: 1698–1702, 1999[Abstract/Free Full Text]
  31. Khan N, Couper JJ: Low-birth-weight infants show earlier onset of IDDM. Diabetes Care 17: 653–656, 1994[Abstract]
  32. Kostraba JN, Cruickshanks KJ, Lawler-Heavner J, Jobim LF, Rewers MJ, Gay EC, Chase HP, Klingensmith G, Hamman RF: Early exposure to cow’s milk and solid food in infancy, genetic predisposition and risk of IDDM. Diabetes Care 42: 288–295, 1993
  33. Wilkin TJ: The accelerator hypothesis: weight gain as the missing link between type I and type II diabetes. Diabetologia 44: 914–922, 2001[Medline]
  34. Patterson CC, Dahlquist G, Soltész G, Green A, on behalf of the EURODIAB ACE Study Group: Is childhood-onset type I diabetes a wealth-related disease? An ecological analysis of European incidence rates. Diabetologia 44 (Suppl. 3): B9–B16, 2001
  35. Tanner JM: Foetus Into Man: Physical Growth From Conception to Maturity. London, Open Books, 1978, p. 150–153

Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Diabetes CareHome page
K. Vehik, R. F. Hamman, D. Lezotte, J. M. Norris, G. Klingensmith, C. Bloch, M. Rewers, and D. Dabelea
Increasing Incidence of Type 1 Diabetes in 0- to 17-Year-Old Colorado Youth
Diabetes Care, March 1, 2007; 30(3): 503 - 509.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
L. Schack-Nielsen and K. F. Michaelsen
Advances in Our Understanding of the Biology of Human Milk and Its Effects on the Offspring
J. Nutr., February 1, 2007; 137(2): 503S - 510S.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
A. Pundziute-Lycka, L.-A. Persson, G. Cedermark, A. Jansson-Roth, U. Nilsson, V. Westin, and G. Dahlquist
Diet, Growth, and the Risk for Type 1 Diabetes in Childhood: A matched case-referent study
Diabetes Care, December 1, 2004; 27(12): 2784 - 2789.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
S. M Virtanen and M. Knip
Nutritional risk predictors of {beta} cell autoimmunity and type 1 diabetes at a young age
Am. J. Clinical Nutrition, December 1, 2003; 78(6): 1053 - 1067.
[Abstract] [Full Text] [PDF]


Home page
The Journal of the Royal Society for the Promotion of HealthHome page
A MacDonald
Is breast best? Is early solid feeding harmful?
The Journal of the Royal Society for the Promotion of Health, September 1, 2003; 123(3): 169 - 174.
[Abstract] [PDF]


Home page
Diabetes CareHome page
A. Pundziute-Lycka, B. Urbonaite, R. Ostrauskas, R. Zalinkevicius, and G. G. Dahlquist
Incidence of Type 1 Diabetes in Lithuanians Aged 0-39 Years Varies by the Urban-Rural Setting, and the Time Change Differs for Men and Women During 1991-2000
Diabetes Care, March 1, 2003; 26(3): 671 - 676.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum